FMC
Develops pesticides and sustainable agricultural solutions
Area Business Manager - Northern Wheatbelt of WA
The role is remote within the Northern Wheatbelt of Western Australia, covering Northampton to Moora and Wongan Hills.
About the job
- A degree in Business, Commerce, or Agricultural Science, or equivalent experience.
- Proven B2B sales or account management success in agriculture or agricultural chemicals; experience in FMCG, industrial, or adjacent sectors is also considered.
- Strong negotiation, planning, and pipeline discipline.
- Strong stakeholder engagement skills across retail networks and end users.
- Ability to work autonomously across a large territory with a proactive and organized approach.
- Full and unrestricted working rights in Australia or New Zealand, including Australian or New Zealand citizenship, permanent residency, or an own valid work visa.
- B2B sales and account management skills and a passion for the agriculture sector.
- Deliver territory sales growth through local initiatives, promotions, and commercial offers.
- Manage key accounts by negotiating terms, planning growth, and creating long-term value.
- Enable and support agency partners through training, stock stewardship, and rotations.
- Partner with technical specialists to run extension activities and launch new products.
- Represent FMC at field days, farmer meetings, and industry events.
- Experience in FMCG, industrial, or adjacent sectors is considered.
About the company
FMC develops and supplies crop protection products, including herbicides, insecticides, and fungicides, plus formulations and technologies that help protect crops from pests and diseases. Its products work by using chemical active ingredients and tailored formulations that control pests while aiming to minimize environmental impact; the company emphasizes science-driven solutions to improve efficacy and safety in farming. Compared with competitors, FMC leverages a long history (over a century) and a clear focus on sustainable technologies that protect both crops and the environment, with ongoing discovery of new actives and innovative formulations. The company’s goal is to help feed the world’s growing population by delivering effective crop protection that is better for the planet.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Philadelphia, Pennsylvania
Founded
1883
Get referred to FMC
See people who can refer or advise you
Simplify's Take
What believers are saying
- Isoflex EU approval on April 6, 2026 opens launches across 55 million hectares.
- FMC expects roughly $1 billion proceeds from Tessenderlo, India, Corteva, and leaseback deals.
- Q2 2026 cash from operations hit $363 million, aided by the $200 million Corteva payment.
What critics are saying
- Q2 2026 revenue fell 17%; 2026 EBITDA guidance now $620 million-$680 million.
- Net debt was $4.3 billion in Q2 2026, forcing covenants and collateral pledges.
- India sale, bond issuance, and strategic review signal a balance-sheet rescue, not growth.
What makes FMC unique
- FMC’s 2026 pipeline includes Isoflex EU approval and rimisoxafen’s first dual-mode classification.
- Tessenderlo’s $400 million investment validates FMC’s asset base and deleveraging plan.
- New active ingredients reached about $200 million sales in 2025, up 54% year-over-year.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Professional Development Budget
Family Planning Benefits
Mental Health Support
Company News
FMC Corporation reported second quarter 2026 revenue of $867 million, down 17% year-over-year, with adjusted EBITDA of $153 million exceeding guidance. Excluding India, revenue fell 20% to $841 million, with organic revenue declining 22%. The company posted a GAAP net loss of $187 million, or $1.49 per diluted share. Adjusted earnings per share reached $0.26, down 62% from the prior year. Cash from operations rose significantly to $363 million, up $297 million year-over-year. FMC lowered its full-year outlook due to challenging macroeconomic conditions. The company now expects revenue excluding India of $3.50 billion to $3.70 billion and adjusted EBITDA between $620 million and $680 million. Free cash flow guidance increased to $75 million to $225 million, including a $200 million upfront licensing payment for rimisoxafen.
Tessenderlo Group has agreed to invest $400 million in FMC Corporation for a 20% stake at $13.30 per share, valuing the agricultural sciences company at approximately $2 billion. The transaction concludes FMC's strategic review initiated in February 2026 and supports its $1 billion debt reduction target. The Belgian industrial group described the investment as part of its strategy to acquire cornerstone minority stakes in high-quality agricultural companies. FMC said the agreement aligns with its operational plans, including advancing its R&D pipeline and commercialising new innovations. The deal follows recent FMC initiatives including a $1.2 billion bond offering, the $252 million sale of its India business, and a $200 million prepayment from Corteva. The transaction requires regulatory approvals and customary closing conditions.
FMC Corporation, a global agricultural sciences company, has reached a definitive agreement with Belgian industrial group Tessenderlo Group for a $400 million minority equity investment at $13.30 per share. Upon completion, Tessenderlo Group will own approximately 20% of FMC's outstanding shares. The transaction concludes FMC's strategic options review announced in February 2026. FMC will use the proceeds to pay down debt, reaching its approximately $1 billion debt paydown target. Recent actions include raising $1.2 billion in secured bonds, selling its India commercial business for $252 million, and securing a $200 million prepayment from a Corteva agreement. The deal is subject to regulatory approvals. BofA Securities and Goldman Sachs advised FMC, whilst Stibbe and Sullivan & Cromwell advised Tessenderlo Group.
FMC Corporation has raised $750 million through senior secured notes due 2031, issued under Regulation S and Rule 144A with guarantees. The fixed-income offering aims to strengthen the company's financial position and provide flexibility for operations, debt management and potential growth initiatives. The financing comes alongside a sharp dividend cut announced in April 2026, from $0.58 to $0.08 per share, signalling management's focus on cash preservation and balance sheet repair. FMC faces elevated leverage and weak interest coverage, making debt management the key near-term catalyst. Whilst the bond issue may ease short-term liquidity pressure, the company's investment narrative still depends on restoring profitability and cash generation in its crop protection business. Some analysts project FMC could reach $4.5 billion in revenue and $429 million in earnings.
FMC Corporation reported first-quarter 2026 sales of $758.6 million and a net loss of $281.3 million, whilst maintaining its full-year 2026 sales guidance of $3.6 billion to $3.8 billion. The company is navigating a planned mid-single-digit price decline and the removal of India sales from its portfolio. Despite the quarterly loss, management's decision to reaffirm annual guidance signals confidence in volume growth and new product launches to offset pricing pressure and the India exit. The company faces ongoing challenges from elevated leverage and weak interest coverage. The narrative projects FMC could reach $4 billion in revenue and $286.1 million in earnings by 2029, with a fair value estimate of $17.53 representing 33% upside. The stock has fallen 11.6% following the announcement.